NZ802195A - Pyrazolopyridine derivatives and uses thereof - Google Patents
Pyrazolopyridine derivatives and uses thereofInfo
- Publication number
- NZ802195A NZ802195A NZ802195A NZ80219522A NZ802195A NZ 802195 A NZ802195 A NZ 802195A NZ 802195 A NZ802195 A NZ 802195A NZ 80219522 A NZ80219522 A NZ 80219522A NZ 802195 A NZ802195 A NZ 802195A
- Authority
- NZ
- New Zealand
- Prior art keywords
- methyl
- pyrazolo
- dione
- dihydropyrimidine
- pyridin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present disclosure relates to compounds of formula (I) and pharmaceutical compositions and their use in reducing Widely Interspaced Zinc Finger Motifs (WIZ) expression levels, or inducing fetal hemoglobin (HbF) expression, and in the treatment of inherited blood disorders (e.g., hemoglobinopathies, e.g., beta-hemoglobinopathies), such as sickle cell disease and beta-thalassemia.
Claims (38)
1. A nd of Formula (I’’) or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer f, wherein: (I’’) is a single bond or a double bond; X is selected from CH, CF, and N; Rx is selected from hydrogen, C1-C6alkyl, halo, C1-C6alkoxyl, and C3-C8cycloalkyl; 10 R’ is selected from hydrogen and C1-C6alkyl; R1 is selected from en and C1-C6alkyl; each R2 is ndently ed from C1-C6alkyl, C1-C6haloalkyl, halo, and oxo, wherein the C1-C6alkyl is tuted with 0-1 occurrence of R2a; or 2 R2 on jacent carbon atoms together with the non-adjacent carbon atoms to which they are attached form a bridging 15 ring; R2a is selected from C1-C6alkoxyl and hydroxyl; R3 is selected from en, C1-C8alkyl, C2-C6alkenyl, –SO2R4, C1-C6haloalkyl, –C(=O)- O-(R5), –C(=O)-(R6), C3-C10cycloalkyl, and a 4- to 10-membered heterocyclyl comprising 1-2 heteroatoms independently selected from N, O and S, wherein the C1-C8alkyl and C1- 20 C6haloalkyl are each independently tuted with 0-3 occurrences of R3a, and wherein the C3- C10cycloalkyl and 4- to 10-membered heterocyclyl are each independently substituted with 0-3 occurrences of R3b; R3 together with the nitrogen atom to which it is attached and R2 together with the carbon 25 atom to which it is attached form a 5- or 6-membered heterocyclyl comprising 0-1 additional heteroatom selected from N, O and S, which 5- or 6-membered heterocyclyl is substituted with 0-2 occurrences of an oxo group; each R3a is independently selected from C3-C10cycloalkyl, a 4- to 10-membered heterocyclyl comprising 1-2 heteroatoms independently selected from N, O and S, a 5- to 10- 30 membered aryl comprising 1-4 heteroatoms independently selected from N, O, and S, C6- C10aryl, C1-C6alkoxyl, hydroxyl, and –C(=O)-NR7R8, wherein the C3-C10cycloalkyl, 4- to 6- membered heterocyclyl, 5- to 10-membered heteroaryl and C6-C10aryl are tuted with 0-4 occurrences of R3b; each R3b is independently ed from C1-C6alkoxyl, halo, C1-C6haloalkyl, C1- C6haloalkoxyl, C1-C6alkyl, -CN, –SO2NR7R8, –SO2R4, and hydroxyl; 5 R4 is selected from C3-C8cycloalkyl, C1-C6alkyl, a 4- to 6-membered heterocyclyl comprising 1-2 heteroatoms independently selected from N, O and S, C6-C10aryl, and –NR4bR4c, wherein the C1-C6alkyl is substituted with 0-1 occurrence of R4a; R4a is ed from C3-C8cycloalkyl, C6-C10aryl, and C1-C6alkoxyl; R4b is selected from hydrogen, and C1-C6alkyl; 10 R4c is selected from hydrogen, C1-C6alkyl, and C3-C8cycloalkyl; R5 is selected from C1-C6alkyl, ycloalkyl, and C6-C10aryl; R6 is selected from C1-C6alkyl, C3-C8cycloalkyl, C6-C10aryl, a 4- to bered heterocyclyl comprising 1-2 heteroatoms independently selected from N, O and S, and– c, wherein the C1-C6alkyl is substituted with 0-1 occurrence of R6a, the C3-C8cycloalkyl is 15 substituted with 0-1 occurrence of R6b, and the 4- to 10-membered heterocyclyl is substituted with 0-1 occurrence of C1-C6alkyl; R6a is selected from C6-C10aryl and ycloalkyl; R6b is selected from halo, C1-C6haloalkyl, C1-C6haloalkoxyl, and C1-C6alkyl; R7 is selected from hydrogen and C1-C6alkyl; 20 R8 is selected from hydrogen and C1-C6alkyl; R7 and R8 together with the nitrogen atom to which they are attached form a 5- or 6- membered heterocyclyl comprising 0-1 additional heteroatom selected from N, O, and S; n is 0, 1, 2, 3 or 4; 25 m is 0, 1 or 2; and p is 0 or 1.
2. A compound of Formula (I’’) or a pharmaceutically acceptable salt, e, solvate, stereoisomer, or er thereof, according to cla im 1, wherein Rx is selected from en, 30 C1-C6alkyl, and halo.
3. The compound of claim 1 or 2 having a Formula (I’) or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, wherein: is a single bond or a double bond; X is ed from CH, CF, and N; 5 R’ is selected from hydrogen and C1-C6alkyl; R1 is selected from hydrogen and C1-C6alkyl; each R2 is independently selected from C1-C6alkyl, C1-C6haloalkyl, halo, and oxo, wherein the C1-C6alkyl is substituted with 0-1 occurrence of R2a; or 2 R2 on non-adjacent carbon atoms together with the non-adjacent carbon atoms to which they are attached form a bridging 10 ring; R2a is ed from C1-C6alkoxyl and hydroxyl; R3 is selected from hydrogen, C1-C8alkyl, C2-C6alkenyl, –SO2R4, C1-C6haloalkyl, –C(=O)- O-(R5) and –C(=O)-(R6), wherein the C1-C8alkyl and aloalkyl are independently substituted with 0-3 occurrences of R3a; 15 or R3 together with the nitrogen atom to which it is attached and R2 together with the carbon atom to which it is attached form a 5- or 6-membered heterocyclyl comprising 0-1 additional atom selected from N, O and S; each R3a is independently selected from C3-C10cycloalkyl, a 4- to 6-membered 20 heterocyclyl comprising 1-2 heteroatoms independently selected from N, O and S, a 5- to 10- membered heteroaryl comprising 1-4 heteroatoms independently selected from N, O, and S, C6- C10aryl, C1-C6alkoxyl, hydroxyl, and –C(=O)-NR7R8, wherein the C3-C10cycloalkyl, 4- to 6- membered heterocyclyl, 5- to 10-membered aryl and aryl are substituted with 0-4 occurrences of R3b; 25 each R3b is independently ed from C1-C6alkoxyl, halo, C1-C6haloalkyl, C1- C6haloalkoxyl, C1-C6alkyl, -CN, –SO2NR7R8, –SO2R4, and hydroxyl; R4 is selected from C3-C8cycloalkyl, C1-C6alkyl, a 4- to 6-membered heterocyclyl comprising 1-2 atoms independently selected from N, O and S, and C6-C10aryl, wherein the C1-C6alkyl is tuted with 0-1 ence of R4a; 30 R4a is selected from C3-C8cycloalkyl, C6-C10aryl, and C1-C6alkoxyl; R5 is selected from C1-C6alkyl C3-C8cycloalkyl, and C6-C10aryl; R6 is selected from C1-C6alkyl, C3-C8cycloalkyl, and C6-C10aryl, wherein the C1-C6alkyl is substituted with 0-1 occurrence of R6a and the C3-C8cycloalkyl is substituted with 0-1 occurrence of R6b; R6a is selected from aryl and C3-C8cycloalkyl; 5 R6b is selected from halo, C1-C6haloalkyl, C1-C6haloalkoxyl, and C1-C6alkyl; R7 is selected from hydrogen and C1-C6alkyl; R8 is selected from hydrogen and C1-C6alkyl; R7 and R8 together with the nitrogen atom to which they are attached form a 5- or 6- 10 membered heterocyclyl comprising 0-1 additional heteroatom selected from N, O, and S; n is 0, 1, 2, 3 or 4; m is 0, 1 or 2; and p is 0 or 1.
4. The compound of any one of claims 1 to 3 having a Formula (I) or a pharmaceutically acceptable salt, e, solvate, stereoisomer, or tautomer thereof, wherein: 15 (I) X is selected from CH, CF, and N; R’ is selected from hydrogen and lkyl; R1 is selected from hydrogen and lkyl; each R2 is independently selected from C1-C6alkyl, C1-C6haloalkyl, halo, and oxo, 20 wherein the lkyl is substituted with 0-1 occurrence of R2a; or 2 R2 on non-adjacent carbon atoms together with the jacent carbon atoms to which they are attached form a bridging ring; R2a is ed from C1-C6alkoxyl and hydroxyl; R3 is selected from hydrogen, C1-C8alkyl, C2-C6alkenyl, –SO2R4, C1-C6haloalkyl, –C(=O)- 25 O-(R5) and –C(=O)-(R6), n the C1-C8alkyl and C1-C6haloalkyl are independently substituted with 0-3 occurrences of R3a; R3 together with the nitrogen atom to which it is attached and R2 together with the carbon atom to which it is attached form a 5- or 6-membered cyclyl sing 0-1 additional heteroatom selected from N, O and S; each R3a is independently selected from C3-C10 cycloalkyl, a 4- to 6-membered 5 cyclyl comprising 1-2 heteroatoms independently selected from N, O and S, a 5- to 10- membered heteroaryl comprising 1-4 heteroatoms independently selected from N, O, and S, C6- C10 aryl, lkoxyl, hydroxyl, and –C(=O)-NR7R8, wherein the C3-C10 cycloalkyl, 4- to 6- membered heterocyclyl, 5- to 10-membered heteroaryl and C6-C10 aryl are substituted with 0-4 ences of R3b ; 10 each R3b is independently selected from C1-C6alkoxyl, halo, C1-C6haloalkyl, C1- C6haloalkoxyl, C1-C6alkyl, -CN, –SO2NR 7R8, –SO 4, 2R and hydroxyl; R4 is ed from C3-C8cycloalkyl, C1-C6alkyl, a 4- to 6-membered cyclyl comprising 1-2 heteroatoms independently selected from N, O and S, and C6-C10 aryl, wherein the C1-C6alkyl is substituted with 0-1 occurrence of R4a ; 15 R4a is selected from C3-C8cycloalkyl, C6-C10 aryl, and C1-C6alkoxyl; R5 is ed from C1-C6alkyl C3-C8cycloalkyl, and C6-C10 aryl; R6 is selected from C1-C6alkyl, C3-C8cycloalkyl, and C6-C10 aryl, wherein the C1-C6alkyl is substituted with 0-1 occurrence of R6a and the C3-C8cycloalkyl is substituted with 0-1 occurrence of R6b ; 20 R6a is selected from C6-C10 aryl and C3-C8cycloalkyl; R6b is selected from halo, C1-C6haloalkyl, C1-C6haloalkoxyl, and C1-C6alkyl; R7 is selected from hydrogen and C1-C6alkyl; R8 is selected from hydrogen and C1-C6alkyl; 25 R7 and R8 together with the nitrogen atom to which they are attached form a 5- or 6- membered heterocyclyl comprising 0-1 additional heteroatom ed from N, O, and S; n is 0, 1, 2, 3 or 4; m is 0, 1 or 2; and p is 0 or 1.
5. The compound of any one of claims 1 to 4, or a ceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, wherein X is selected from CH, CF, and N; R’ is selected from hydrogen and C1-C3alkyl; 35 R1 is selected from hydrogen and C1-C3alkyl; each R2 is independently selected from unsubstituted C1-C6alkyl, C1-C6haloalkyl and halo; or 2 R2 on non-adjacent carbon atoms er with the non-adjacent carbon atoms to which they are attached form a bridging ring; R3 is selected from hydrogen, C1-C8alkyl, C2-C6alkenyl, –SO2R4, C1-C6haloalkyl, –C(=O)- O-(R 5) and –C(=O)-(R6), wherein the C 1-C8alkyl and C1-C6haloalkyl are independently substituted with 0-3 occurrences of R3a ; 5 R3 together with the nitrogen atom to which it is attached and R2 together with the carbon atom to which it is attached form a 5- or 6-membered heterocyclyl sing 0-1 additional atom selected from N and O; each R3a is independently selected from C3-C10 cycloalkyl, a 4- to 6-membered heterocyclyl comprising 1-2 heteroatoms independently selected from N, O and S, a 5- to 10- 10 membered heteroaryl comprising 1-4 heteroatoms independently ed from N, O, and S, C6- C10 aryl, C1-C6alkoxyl, hydroxyl, and –C(=O)-NR7R8, wherein the C3-C10 cycloalkyl, 4- to 6- membered heterocyclyl, 5- to 10-membered heteroaryl and C6-C10 aryl are substituted with 0-4 occurrences of R3b ; each R3b is independently selected from C1-C6alkoxyl, halo, aloalkyl, C1- 15 alkoxyl, C1-C6alkyl, -CN, –SO2NR 7R8, –SO 4, 2R and hydroxyl; R4 is selected from ycloalkyl, C1-C6alkyl, a 4- to 6-membered heterocyclyl comprising 1-2 heteroatoms independently selected from N, O and S, and C6-C10 aryl, wherein the C1-C6alkyl is substituted with 0-1 occurrence of R4a ; R4a is selected from C3-C8cycloalkyl, C6-C10 aryl, and C1-C6alkoxyl; 20 R5 is selected from C1-C6alkyl C3-C8cycloalkyl, and C6-C10 aryl; R6 is selected from lkyl, ycloalkyl, and C6-C10 aryl, wherein the C1-C6alkyl is substituted with 0-1 occurrence of R6a and the C3-C8cycloalkyl is substituted with 0-1 occurrence of R6b ; R6a is selected from C6-C10 aryl and C3-C8cycloalkyl; 25 R6b is selected from chloro, fluoro, C1-C6haloalkyl, C1-C6haloalkoxyl, and C1-C6alkyl; R7 is selected from hydrogen and C1-C6alkyl; R8 is ed from hydrogen and C1-C6alkyl; R7 and R8 together with the nitrogen atom to which they are attached form a 5- or 6- 30 membered heterocyclyl comprising 0-1 additional heteroatom selected from N, O, and S; n is 0, 1, 2 or 3; m is 0, 1 or 2; and p is 0 or 1. 35
6. The compound of any one of claims 1 to 5, or a pharmaceutically acceptable salt, hydrate, e, stereoisomer, or tautomer f, wherein X is selected from CH and N; R’ is hydrogen; R1 is hydrogen; each R2 is independently selected from unsubstituted lkyl; or 2 R2 on nonadjacent carbon atoms together with the non-adjacent carbon atoms to which they are attached form a C1-C3alkylene bridging ring; R3 is selected from C1-C8alkyl, C2-C6alkenyl, –SO2R4 and unsubstituted C1-C6haloalkyl, 5 wherein the C1-C8alkyl is substituted with 0-2 occurrences of R3a; each R3a is independently selected from C3-C10cycloalkyl, a 4- to 6-membered heterocyclyl comprising 1-2 heteroatoms independently selected from N and O, a 5- to 6- membered aryl sing 1-3 heteroatoms ndently selected from N, O, and S and phenyl, wherein the C3-C10cycloalkyl, 4- to 6-membered heterocyclyl, 5- to 6-membered 10 heteroaryl and phenyl are substituted with 0-3 occurrences of R3b; each R3b is independently selected from halo, C1-C6haloalkyl, C1-C6haloalkoxyl, C1- C6alkyl, and hydroxyl; R4 is selected from C3-C8cycloalkyl, C1-C6alkyl, a 4- to ered heterocyclyl comprising 1-2 heteroatoms independently selected from N, O and S, and C6-C10aryl, wherein 15 the C1-C6alkyl is substituted with 1 occurrence of R4a; R4a is selected from C3-C8cycloalkyl, C6-C10aryl, and C1-C6alkoxyl; n is 0, 1 or 2; m is 1 or 2; and p is 1.
7. The compound of any one of claims 1 to 6, or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, wherein R3 is selected from C1-C6alkyl and 25 8. The compound of any one of claims 1 to 7, or a pharmaceutically acceptable salt, hydrate, solvate, isomer, or tautomer thereof, having a Formula (Ia):
8. (Ia). 30
9. The compound of any one of claims 1 to 8, or a ceutically acceptable salt, hydrate, solvate, isomer, or tautomer thereof, having a Formula (Id), wherein, X is selected from N and CH; 5 R2b is selected from hydrogen, C1-C6alkyl, C1-C6haloalkyl, and halo, wherein the C1- C6alkyl is substituted with 0-1 occurrence of R2a; R2c is selected from hydrogen and C1-C6alkyl, wherein the lkyl is substituted with 0-1 occurrence of R2a; or R2b and R2c together with the carbon atoms to which they are attached form an oxo 10 group; R2e is selected from hydrogen, C1-C6alkyl, C1-C6haloalkyl, halo, and oxo, wherein the C1- C6alkyl is substituted with 0-1 occurrence of R2a; or R2b and R2e er with the carbon atoms to which they are attached form a bridging ring; 15 R2a is selected from C1-C6alkoxyl and hydroxyl; and R3 is defined according to any one of claims 1 to 8.
10. The nd of any one of claims 1 to 9, or a pharmaceutically acceptable salt, 20 hydrate, solvate, stereoisomer, or tautomer f, wherein R2 is unsubstituted C1-C6alkyl and n is 1.
11. The compound of any one of claims 1 to 10, or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, wherein m is 1.
12. The compound of any one of claims 1 to 11, or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, wherein R3 is selected from , ethyl, npropyl , i-propyl, 2-propanyl, butyl, i-butyl, 2-butanyl, 3-methylbutanyl, yl, 3-pentanyl, tyl, 2,4-dimethylpentanyl, and –CH2-(CH2)0R3a.
13. The compound of any one of claims 1 to 3, or a ceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, wherein is a double bond.
14. The compound of any one of claims 1 to 3, or a pharmaceutically acceptable salt, 5 hydrate, solvate, stereoisomer, or tautomer thereof, wherein is a single bond.
15. The compound of claim 1 or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer f, selected from: 1-(5-((1-(((1s,4s) 1-(5-((1-(5-fluoromethylbenzyl)piperidin methoxycyclohexyl)methyl)piperidin hyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin ydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (R)(5-((hexahydropyrrolo[1,2-a]pyrazin- 1-(5-((1-(((1r,4r) 2(1H)-yl)methyl)pyrazolo[1,5-a]pyridin methoxycyclohexyl)methyl)piperidin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione methyl 4-((3-(2,4-dioxotetrahydropyrimidin- 1-(5-((1-(cyclohexylsulfonyl)piperidin 1(2H)-yl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)piperidinecarboxylate yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-acetylpiperidin 1-(5-((1-(cyclohexylmethyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin hyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)((4,4- 1-(5-((1-(4-methoxybenzyl)piperidin difluorocyclohexyl)methyl)methylpiperidinyl )methyl)pyrazolo[1,5-a]pyridin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(cyclopentylmethyl)piperidin phenyl 4-((3-(2,4-dioxotetrahydropyrimidinyl )methyl)pyrazolo[1,5-a]pyridin 1(2H)-yl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)methyl)piperidinecarboxylate 1-(5-(((1R,5S)isobutyl 1-(5-((1-((tetrahydro-2H-pyran azabicyclo[3.2.1]octan hyl)piperidinyl)methyl)pyrazolo[1,5- hyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-((1-(thiazolylmethyl)piperidin 1-(5-((1-(cyclopentylsulfonyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((3S,5S)isobutyl-3,5- 1-(5-((1-((4,4- dimethylpiperazinyl)methyl)pyrazolo[1,5- difluorocyclohexyl)methyl)piperidin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione (S)(5-((3-methyl(pyridin 1-(5-((1-((tetrahydro-2H-pyran ylmethyl)piperazinyl)methyl)pyrazolo[1,5- yl)sulfonyl)piperidinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione (S)(5-((3-ethyl((tetrahydro-2H-pyran yl)methyl)piperazinyl)methyl)pyrazolo[1,5- 1-(5-((1-(cyclopropylmethyl)piperidin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)methyl((tetrahydro-2H- 1-(5-((1-(2-oxo(piperidin 4-yl)methyl)piperidin yl)ethyl)piperidinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-((1-isobutyrylpiperidin 1-(5-((1-(2-cyclohexylethyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione ydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)(cyclohexylmethyl) 1-(5-((4-fluoroisobutylpiperidin methylpiperidinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione N N N 1-(5-((1-((cyclohexylmethyl)sulfonyl)piperidin- 1-(5-((1-(2-chlorobenzyl)piperidin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1- 1-(5-((4-(2-methylbenzyl)piperazin ((cyclopropylmethyl)sulfonyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione ydropyrimidine-2,4(1H,3H)-dione N O 1-(5-(((2S,4R)(cyclopentylmethyl) 1-(5-(((1R,5S)(pyridinylmethyl) methylpiperidinyl)methyl)pyrazolo[1,5- azabicyclo[3.2.1]octan a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione N N N 1-(5-((1-((tetrahydro-2H-pyran hyl)piperidinyl)methyl)pyrazolo[1,5- 1-(5-((4-(4-fluorobenzyl)piperazin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((4-(cyclohexylmethyl)piperazin 1-(5-((1-(pyridinylmethyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin hyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(2-methoxybenzyl)piperidin (S)(5-((4-((4,4-difluorocyclohexyl)methyl)- yl)methyl)pyrazolo[1,5-a]pyridin 3-methylpiperazinyl)methyl)pyrazolo[1,5- yl)dihydropyrimidine-2,4(1H,3H)-dione a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione 1-(5-((1-(2-(tetrahydro-2H-pyranyl)propan- 2-yl)piperidinyl)methyl)pyrazolo[1,5- 1-(5-((1-(cyclobutylmethyl)fluoropiperidina ]pyridinyl)dihydropyrimidine-2,4(1H,3H)- 4-yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione (S)(5-((3-ethylisobutylpiperazin 1-(5-(((S)(((1r,4S) yl)methyl)pyrazolo[1,5-a]pyridin methoxycyclohexyl)methyl) yl)dihydropyrimidine-2,4(1H,3H)-dione piperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione 1-(5-((4-(2-fluoromethylpropyl)piperazin (S)(5-((4-(cyclohexylmethyl) yl)methyl)pyrazolo[1,5-a]pyridin methylpiperazinyl)methyl)pyrazolo[1,5- yl)dihydropyrimidine-2,4(1H,3H)-dione a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione 1-(5-((4-(3-methylbenzyl)piperazin 1-(5-(((S)(((1s,4R) yl)methyl)pyrazolo[1,5-a]pyridin methoxycyclohexyl)methyl) yl)dihydropyrimidine-2,4(1H,3H)-dione methylpiperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione 1-(5-((1-(cycloheptylmethyl)piperidin 1-(5-((1-(thiazolylmethyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin hyl)pyrazolo[1,5-a]pyridin ydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4S)(cyclohexylmethyl) (S)(5-((4-(cyclohexylmethyl) methylpiperidinyl)methyl)pyrazolo[1,5- methylpiperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione (S)(5-((3-methyl((tetrahydro-2H-pyran- (R)(5-((4-(cyclohexylmethyl) 4-yl)methyl)piperazin (methoxymethyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(2-methylbutyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin 1-(5-((4-(3-fluorobenzyl)piperazin ydropyrimidine-2,4(1H,3H)-dione yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(2-cyclohexylpropyl)piperidin 1-(5-((4-(2,2,2-trifluoroethyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (R)(5-((4-isobutyl 1-(5-((1-(2-(tetrahydro-2H-pyran (methoxymethyl)piperazin yl)ethyl)piperidinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione (S)(5-((4-isobutylmethylpiperazin 1-(5-((1-(cyclohexanecarbonyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)isobutylmethylpiperidin (S)(5-((2-methyl((tetrahydro-2H-pyranyl )methyl)pyrazolo[1,5-a]pyridin 4-yl)methyl)piperazin yl)dihydropyrimidine-2,4(1H,3H)-dione hyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione (S)(5-((4-(cyclopentylmethyl) 1-(5-((4-(pyridinylmethyl)piperazin methylpiperazinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-((1-(3-hydroxy (1-(heptanyl)piperidin (hydroxymethyl)propyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((4-((1-methyl-1H-pyrazol yl)methyl)piperazinyl)methyl)pyrazolo[1,5- 1-(5-((1-(2-cyclobutylethyl)piperidin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione (S)(5-((1-((tetrahydrofuran 1-(5-((3,3-dimethyl((tetrahydro-2H-pyranyl )methyl)piperidinyl)methyl)pyrazolo[1,5- 4-yl)methyl)piperazin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((4-(isopropylsulfonyl)piperazin (S)(5-((4-isopentylmethylpiperazin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(2-cyclopentylethyl)piperidin (S)(5-((4-((3,3-difluorocyclobutyl)methyl) yl)methyl)pyrazolo[1,5-a]pyridin methylpiperazinyl)methyl)pyrazolo[1,5- yl)dihydropyrimidine-2,4(1H,3H)-dione a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione (R)(5-((1-((tetrahydrofuran (S)(5-((4-(cyclobutylmethyl) yl)methyl)piperidinyl)methyl)pyrazolo[1,5- methylpiperazinyl)methyl)pyrazolo[1,5- dinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione tert-butyl 4-((3-(2,4-dioxotetrahydropyrimidin- 1-(5-((4-((4,4- 1(2H)-yl)pyrazolo[1,5-a]pyridin difluorocyclohexyl)methyl)piperazin yl)methyl)piperidinecarboxylate yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione (4-(3,3,3-trifluoro-2,2- 1-(5-((1-(isopropylsulfonyl)piperidin ylpropyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (S)(5-((4-((3,3-difluorocyclobutyl)methyl) isobutyl 4-((3-(2,4-dioxotetrahydropyrimidinmethylpiperazinyl )methyl)pyrazolo[1,5- 1(2H)-yl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)piperidinecarboxylate dione N N N 1-(5-((4-(cycloheptylmethyl)piperazin 1-(5-(((1R,5S)(cyclohexylmethyl)-3,8- yl)methyl)pyrazolo[1,5-a]pyridin diazabicyclo[3.2.1]octan yl)dihydropyrimidine-2,4(1H,3H)-dione yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((1R,4R)(cyclohexylmethyl)-2,5- 1-(5-((4-(((1r,4r) diazabicyclo[2.2.1]heptan methoxycyclohexyl)methyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((4-((1- (trifluoromethyl)cyclopropyl)methyl)piperazin- 1-(5-((1-(pyridinylmethyl)piperidin 1-yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-isobutylpiperidin (4-(2,2,3,3-tetrafluoropropyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)(cyclobutylmethyl) 1-(5-((1-(1-(trifluoromethyl)cyclopropane methylpiperidinyl)methyl)pyrazolo[1,5- carbonyl)piperidinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione (1-((3,3- cyclohexyl 4-((3-(2,4- difluorocyclobutyl)methyl)piperidin dioxotetrahydropyrimidin-1(2H)- yl)methyl)pyrazolo[1,5-a]pyridin yl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)methyl)piperidinecarboxylate (4-((1-methyl-1H-imidazol yl)methyl)piperazinyl)methyl)pyrazolo[1,5- 1-(5-((1-(oxetanylmethyl)piperidin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-((tetrahydrofuran 1-(5-((4-isobutyl-3,3-dimethylpiperazin yl)methyl)piperidinyl)methyl)pyrazolo[1,5- hyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-((1-(3-phenylpropanoyl)piperidin 1-(5-((4-((tetrahydro-2H-pyran yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)piperazinyl)methyl)pyrazolo[1,5- yl)dihydropyrimidine-2,4(1H,3H)-dione a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione 1-(5-((4-(thiazolylmethyl)piperazin 1-(5-((1-(cyclobutylmethyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-isopentylpiperidin 1-(5-((4-(1-(pyridinyl)ethyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-((1-methyl-1H-imidazol (S)(5-((4-(cyclobutylmethyl) yl)methyl)piperidinyl)methyl)pyrazolo[1,5- methylpiperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione 1-(5-((4-(((1s,4s) 1-(5-((4-(pyridinylmethyl)piperazin methoxycyclohexyl)methyl)piperazin hyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((4-((3,3- 1-(5-((1-(piperidinylmethyl)piperidin difluorocyclobutyl)methyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin hyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(((1r,4r) ethoxycyclohexyl)methyl)piperidin 1-(5-(((1R,4R)(pyridinylmethyl)-2,5- yl)methyl)pyrazolo[1,5-a]pyridin diazabicyclo[2.2.1]heptan yl)dihydropyrimidine-2,4(1H,3H)-dione yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((4-(cyclopentylmethyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(piperidinylmethyl)pyrazolo[1,5- 1-(5-((1-(sec-butylsulfonyl)piperidin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((4-(2-(tetrahydro-2H-pyran 1-(5-((1-benzoylpiperidin yl)ethyl)piperazinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-(((2S)methyl((tetrahydrofuran (1-(2,2,2-trifluoroethyl)piperidin yl)methyl)piperazinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-((4-(1-(trifluoromethyl)cyclopropane 1-(5-((4-(2-cyclohexylethyl)piperazin carbonyl)piperazinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-((4-((tetrahydro-2H-pyran 1-(5-((1-(3-cyclohexylpropanoyl)piperidin yl)methyl)piperazinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-(((1R,5S)(pyridinylmethyl)-3,8- 1-(5-((4-isobutylpiperazin icyclo[3.2.1]octan hyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (R)(5-((3-methyl(pyridin ylmethyl)piperazinyl)methyl)pyrazolo[1,5- 1-(5-((1-(pentanyl)piperidin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((1S,4S)(isopropylsulfonyl)-2,5- 1-(5-((1-neopentylpiperidin diazabicyclo[2.2.1]heptan hyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((1R,5S)(3-fluorobenzyl)-3,8- diazabicyclo[3.2.1]octan 1-(5-((1-(isobutylsulfonyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin ydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (R)(5-((3-(difluoromethyl) 1-(5-(((3S,5R)-3,5-dimethyl((tetrahydroisobutylpiperazinyl )methyl)pyrazolo[1,5- 2H-pyranyl)methyl)piperazin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione (S)(5-((3-methyl(2-(tetrahydro-2H- 1-(5-((4-(2-cyclohexylethyl)oxopiperazin pyranyl)ethyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione ydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-((1-fluorocyclohexyl)methyl)piperidin- 1-(5-((4-(cyclohexylmethyl)oxopiperazin ethyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((1S,4S)(pyridinylmethyl)-2,5- 1-(5-((1-(1-(pyridinyl)ethyl)piperidin diazabicyclo[2.2.1]heptan yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione ((1S,4S)(cyclohexylmethyl)-2,5- 1-(5-((1-(benzylsulfonyl)piperidin diazabicyclo[2.2.1]heptan yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (S)(5-((4-isobutylisopropylpiperazin 1-(5-((4-(cyclobutylmethyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin hyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(2-methyl(tetrahydro-2H-pyran (R)(5-((4-(cyclohexylmethyl) yl)propanyl)piperidin (difluoromethyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((1R,4R)(isopropylsulfonyl)-2,5- diazabicyclo[2.2.1]heptan 1-(5-((1-(3-fluorobenzyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin ydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((4-isobutyloxopiperazin 1-(5-((1-(4-fluorobenzyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(cyclopropylsulfonyl)piperidin (5-((3-isopropyl((tetrahydro-2H- yl)methyl)pyrazolo[1,5-a]pyridin pyranyl)methyl)piperazin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(methylsulfonyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin 1-(5-((4-(cyclohexylmethyl)oxopiperazin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione (R)(5-((3-methyl((tetrahydro-2H-pyran- (1-ethylpiperidin 4-yl)methyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin ydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(((3r,5r,7r)-adamantan 1-(5-((4-((tetrahydrofuran yl)methyl)piperidinyl)methyl)pyrazolo[1,5- yl)methyl)piperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione N N N (S)(5-((4-(cycloheptylmethyl) F3C methylpiperazinyl)methyl)pyrazolo[1,5- 1-(5-((1-(3-(trifluoromethyl)benzyl)piperidin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(1-phenylethyl)piperidin 1-(5-((1-(2-cyclobutylpropanyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione ((3S)(((2R,6S)-2,6- 1-(5-((1-(3-(trifluoromethoxy)benzyl)piperidin- dimethyltetrahydro-2H-pyranyl)methyl) 4-yl)methyl)pyrazolo[1,5-a]pyridin methylpiperazinyl)methyl)pyrazolo[1,5- yl)dihydropyrimidine-2,4(1H,3H)-dione a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione 1-(5-(((2S,4R)(cycloheptylmethyl) 1-(5-((4-propylpiperazin methylpiperidinyl)methyl)pyrazolo[1,5- hyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione (R)(5-((4-isobutylmethylpiperazin 1-(5-((4-phenethylpiperazin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (R)(5-((2-methyl((tetrahydro-2H-pyran- 1-(5-(((3S)methyl((tetrahydrofuran 4-yl)methyl)piperazin yl)methyl)piperazinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-((4-(((2R,6S)-2,6-dimethyltetrahydro-2H- 1-(5-((1-(pyridinylmethyl)piperidin 4-yl)methyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin hyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((3S,5R)isobutyl-3,5- 1-(1-isobutylpiperidin dimethylpiperazinyl)methyl)pyrazolo[1,5- yl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-((1-benzylpiperidin 1-(5-((1-benzylfluoropiperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)((3,3- difluorocyclobutyl)methyl)methylpiperidin- 1-(5-((1-(2,2,3,3-tetrafluoropropyl)piperidin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((4-(((3r,5r,7r)-adamantan yl)methyl)piperazinyl)methyl)pyrazolo[1,5- 1-(5-((1-(phenylsulfonyl)piperidin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-((5-fluoropyridin 1-(5-(((2R,4R)methyl((tetrahydro-2H- yl)methyl)piperidinyl)methyl)pyrazolo[1,5- pyranyl)methyl)piperidin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione ydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(2-methoxyethyl)piperidin 1-(5-((1-(((2R,6S)-2,6-dimethyltetrahydro-2H- yl)methyl)pyrazolo[1,5-a]pyridin pyranyl)methyl)piperidin ydropyrimidine-2,4(1H,3H)-dione yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(3,3,3-trifluoro-2,2- dimethylpropyl)piperidin 1-(5-((1-(2,4-dimethylpentanyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(2-hydroxyethyl)piperidin ((2R,4S)isobutylmethylpiperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-((5-methylpyridin 1-(5-(((2S,4S)isobutylmethylpiperidin yl)methyl)piperidinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-(((1R,5S)(cyclohexylmethyl) azabicyclo[3.2.1]octan 1-(5-(((3S)methyl((tetrahydrofuran yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)piperazinyl)methyl)pyrazolo[1,5- yl)dihydropyrimidine-2,4(1H,3H)-dione a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione 1-(5-((1-isopropylpiperidin 1-(5-((4-(cyclohexylmethyl)-3,3- yl)methyl)pyrazolo[1,5-a]pyridin dimethylpiperazinyl)methyl)pyrazolo[1,5- yl)dihydropyrimidine-2,4(1H,3H)-dione a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione 1-(5-(((2S,4S)methyl((tetrahydro-2H- 1-(5-((1-(2-fluorobenzyl)piperidin pyranyl)methyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2R,4S)methyl((tetrahydro-2H- 1-(5-((1-(2-fluoromethylpropyl)piperidin pyranyl)methyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin hyl)pyrazolo[1,5-a]pyridin ydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (R)(5-((hexahydropyrazino[2,1- 1-(5-((1-((tetrahydrofuran c][1,4]oxazin-8(1H)-yl)methyl)pyrazolo[1,5- yl)methyl)piperidinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione (4-(cyclopropylmethyl)piperazin 1-(5-(((2R,4R)(cyclohexylmethyl) yl)methyl)pyrazolo[1,5-a]pyridin methylpiperidinyl)methyl)pyrazolo[1,5- yl)dihydropyrimidine-2,4(1H,3H)-dione a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione (S)(5-((hexahydropyrazino[2,1- (R)(5-((4-(cyclohexylmethyl) c][1,4]oxazin-8(1H)-yl)methyl)pyrazolo[1,5- methylpiperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione 1-(5-(((2R,4R)isobutylmethylpiperidin 1-(5-((1-(3-methoxybenzyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione N N N 1-(5-(((S)(((1r,4S) 1-(5-((1-(2-methylbenzyl)piperidin hydroxycyclohexyl)methyl) yl)methyl)pyrazolo[1,5-a]pyridin methylpiperazinyl)methyl)pyrazolo[1,5- yl)dihydropyrimidine-2,4(1H,3H)-dione a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione 1-(5-((1-(2-(4,4-difluorocyclohexyl)propan yl)piperidinyl)methyl)pyrazolo[1,5- (1-(3-fluoromethylbenzyl)piperidin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione ((2R,4S)((4,4- 1-(5-((1-(2,2-difluoroethyl)piperidin difluorocyclohexyl)methyl)methylpiperidinyl )methyl)pyrazolo[1,5-a]pyridin 4-yl)methyl)pyrazolo[1,5-a]pyridin ydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4S)((4,4- difluorocyclohexyl)methyl)methylpiperidin- 1-(5-((1-(3,5-difluorobenzyl)piperidin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(3-methylbutanyl)piperidin 1-(5-((1-(3,4-difluorobenzyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((4-(pentanyl)piperazin 1-(5-((4-(3-methylbutanyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione ydropyrimidine-2,4(1H,3H)-dione (S)(5-((4-((4,4-dimethylcyclohexyl)methyl)- 3-methylpiperazinyl)methyl)pyrazolo[1,5- 1-(5-((1-((6-methylpyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)piperidinyl)methyl)pyrazolo[1,5- dione a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione 1-(5-(((2S,4R)methyl(2-(tetrahydro-2H- 1-(5-((1-(4-methylbenzyl)piperidin 4-yl)ethyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione N N N 1-(5-(((2R,4R)((4,4- difluorocyclohexyl)methyl)methylpiperidin- 1-(5-((1-((2-methoxyethyl)sulfonyl)piperidin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione ((3S,5S)(cyclohexylmethyl)-3,5- 1-(5-((4-(2-(4,4-difluorocyclohexyl)propan dimethylpiperazinyl)methyl)pyrazolo[1,5- yl)piperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione 1-(5-(((2S,4R)((4,4- 1-(5-((1-(cyclohexylmethyl)piperidin dimethylcyclohexyl)methyl)methylpiperidinyl )methyl)methylpyrazolo[1,5-a]pyridin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione ((2S,4R)methyl(pyridin 1-(5-((4-benzylpiperazin ylmethyl)piperidinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-((1-(((1r,4r) hydroxycyclohexyl)methyl)piperidin 1-(5-((1-(cyclohexylmethyl)fluoropiperidin- yl)methyl)pyrazolo[1,5-a]pyridin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (S)(5-((hexahydropyrrolo[1,2-a]pyrazin- ((2S,4R)(((1r,4S) 2(1H)-yl)methyl)pyrazolo[1,5-a]pyridin methoxycyclohexyl)methyl) yl)dihydropyrimidine-2,4(1H,3H)-dione methylpiperidinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione HN N N 1-(5-((1-(2-methylallyl)piperidin 1-(5-((1,4-diazepanyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-((1-(2-hydroxymethylpropyl)piperidin- 1-(5-((4-isobutyl-1,4-diazepan 4-yl)methyl)pyrazolo[1,5-a]pyridin hyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (S)(5-((octahydro-2H-pyrido[1,2-a]pyrazin- 1-(5-((4-(cyclohexylmethyl)-1,4-diazepan 2-yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione ydropyrimidine-2,4(1H,3H)-dione 1-(5-(azetidinylmethyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- 1-(5-((1-(1-(3-fluorophenyl)ethyl)piperidin dione yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-((1-methyl-1H-pyrazol (1-isobutylazetidin yl)methyl)piperidinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-((1-(cyclohexylmethyl)azetidin yl)methyl)pyrazolo[1,5-a]pyridin 1-(5-((4-(2-(tetrahydro-2H-pyranyl)propanyl )dihydropyrimidine-2,4(1H,3H)-dione 2-yl)piperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione 1-(5-((1-methylpiperidin yl)methyl)pyrazolo[1,5-a]pyridin (1-(cyclohexylmethyl)pyrrolidin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(pyridinylmethyl)pyrrolidin 1-(5-((1-(2,4-difluorobenzyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (R)(5-((4-isobutylmethylpiperazin 1-(5-((1-(cyclobutylmethyl)pyrrolidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (1-(3-fluoro (trifluoromethyl)benzyl)piperidin 1-(5-((1-(3-fluorobenzyl)pyrrolidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(2-(1H-imidazolyl)ethyl)piperidin 1-(5-((1-isobutylpyrrolidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione ydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)(((3R,4S)-3,4- 1-(5-((1-(2-cyclohexyl-2,2- difluorocyclopentyl)methyl)methylpiperidindifluoroethyl )piperidin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((4-isopropylpiperazin (5-((octahydro-2H-pyrido[1,2-a]pyrazinyl )methyl)pyrazolo[1,5-a]pyridin 2-yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((4-(((1r,4r) 1-(5-((1-isobutyl-2,2-dimethylpiperidin hydroxycyclohexyl)methyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin hyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)(isopropylsulfonyl) methylpiperidinyl)methyl)pyrazolo[1,5- 1-(5-((1-(2,3-difluorobenzyl)piperidin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)methyl((tetrahydro-2H- (R)(5-((4-(cyclohexylmethyl) pyranyl)sulfonyl)piperidin methylpiperazinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-((4-(2-hydroxymethylpropyl)piperazin- 1-(5-(((2S,4R)methyl(2,2,3,3- 1-yl)methyl)pyrazolo[1,5-a]pyridin tetrafluoropropyl)piperidin yl)dihydropyrimidine-2,4(1H,3H)-dione hyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)(((1s,3R) methoxycyclobutyl)methyl)methylpiperidin- (1-((6-(trifluoromethyl)pyridin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)piperidinyl)methyl)pyrazolo[1,5- yl)dihydropyrimidine-2,4(1H,3H)-dione a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione 1-(5-(((S)(((1s,3R) methoxycyclobutyl)methyl) 1-(5-((1-((3-methyloxetan methylpiperazinyl)methyl)pyrazolo[1,5- yl)methyl)piperidinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione 1-(5-((1-((1- 1-(5-((1-(((1s,3s) (trifluoromethyl)cyclopropyl)methyl)piperidin- methoxycyclobutyl)methyl)piperidin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)(((1r,3S) 1-(5-((1-(2-methoxymethylpropyl)piperidinmethoxycyclobutyl )methyl)methylpiperidin- 4-yl)methyl)pyrazolo[1,5-a]pyridin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione ydropyrimidine-2,4(1H,3H)-dione 1-(5-(((S)(((1r,3S) methoxycyclobutyl)methyl) (S)(5-((4-isobutylmethylpiperazin piperazinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-((1-(((3R,4S)-3,4- difluorocyclopentyl)methyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-((1-(4-(trifluoromethoxy)benzyl)piperidin- 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione ((3S)(((3R,4S)-3,4- difluorocyclopentyl)methyl) methylpiperazinyl)methyl)pyrazolo[1,5- 1-(5-((1-(4-(trifluoromethyl)benzyl)piperidin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((9aR)-octahydro-2H-quinolizin 1-(5-(((2S,4R)(isopropylsulfonyl) yl)methyl)pyrazolo[1,5-a]pyridin methylpiperidinyl)methyl)pyrazolo[1,5- yl)dihydropyrimidine-2,4(1H,3H)-dione dinyl)dihydropyrimidine-2,4(1H,3H)- dione 1-(5-(((2S,4R)methyl((tetrahydro-2H- 1-(5-(((2S,4R)methyl(2,2,3,3- pyranyl)sulfonyl)piperidin tetrafluoropropyl)piperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)(((1r,3S) 1-(5-(((2S,4R)(((1s,3R) methoxycyclobutyl)methyl)methylpiperidin- methoxycyclobutyl)methyl)methylpiperidin- 4-yl)methyl)pyrazolo[1,5-a]pyridin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((S)(((1r,3S) 1-(5-(((S)(((1s,3R) methoxycyclobutyl)methyl) methoxycyclobutyl)methyl) methylpiperazinyl)methyl)pyrazolo[1,5- methylpiperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione ((2S,4R)(((R)-3,3- 1-(5-(((2S,4R)(((S)-3,3- difluorocyclopentyl)methyl)methylpiperidin- difluorocyclopentyl)methyl)methylpiperidin- 4-yl)methyl)pyrazolo[1,5-a]pyridin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione ((S)(((R)-3,3- 1-(5-(((S)(((S)-3,3- rocyclopentyl)methyl) difluorocyclopentyl)methyl) methylpiperazinyl)methyl)pyrazolo[1,5- methylpiperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione 1-(5-(((S)(((1r,3R,4S)-3,4- 1-(5-(((2S,4R)(((1r,3R,4S)-3,4- difluorocyclopentyl)methyl) difluorocyclopentyl)methyl)methylpiperidinmethylpiperazinyl )methyl)pyrazolo[1,5- 4-yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione ((2S,4R)((4,4- 1-(5-(azepanylmethyl)pyrazolo[1,5- difluorocyclohexyl)methyl)methylpiperidin- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- 4-yl)methyl)pyrazolo[1,5-a]pyridin dione yl)pyrimidine-2,4(1H,3H)-dione utyl 4-((3-(2,4-dioxotetrahydropyrimidin- 1-(5-((1-methylazepan 1(2H)-yl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)azepanecarboxylate yl)dihydropyrimidine-2,4(1H,3H)-dione (1-(cyclohexylmethyl)azepan 1-(5-(((2S,4R)methyl(2,2,3,3- yl)methyl)pyrazolo[1,5-a]pyridin tetrafluoropropyl)piperidin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)(2,2-difluoroethyl) 1-(5-(((2S,4R)methyl(2,2,2- methylpiperidinyl)methyl)pyrazolo[1,5- trifluoroethyl)piperidin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)methyl(3,3,3- 1-(5-(((2S,4R)methyl(oxetan trifluoropropyl)piperidin ylmethyl)piperidinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- ydropyrimidine-2,4(1H,3H)-dione dione 1-(5-(((2S,4R)(2,2-difluoro 1-(5-(((2S,4R)methyl(oxetan methoxypropyl)methylpiperidin yl)piperidinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-(((2S,4R)cyclobutylmethylpiperidin- 1-(5-((1-(oxetanyl)piperidin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)(ethylsulfonyl) 1-(5-((1-cyclobutylpiperidin methylpiperidinyl)methyl)pyrazolo[1,5- hyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-(((2S,4R)methyl 1-(5-(((2S,4R)(isopropylsulfonyl) (methylsulfonyl)piperidin methylpiperidinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione N N N 1-(5-(((2S,4R)(cyclopropylsulfonyl) 1-(5-(((2S,4R)(cyclopropanecarbonyl) methylpiperidinyl)methyl)pyrazolo[1,5- methylpiperidinyl)methyl)pyrazolo[1,5- dinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione 1-(5-(((2S,4R)isobutyrylmethylpiperidin- 1-(5-(((2S,4R)(cyclobutanecarbonyl) 4-yl)methyl)pyrazolo[1,5-a]pyridin methylpiperidinyl)methyl)pyrazolo[1,5- yl)dihydropyrimidine-2,4(1H,3H)-dione a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione NO N N 1-(5-(((2S,4R)methyl(pyrrolidin 1-(5-(((2S,4R)methyl(1- ylsulfonyl)piperidinyl)methyl)pyrazolo[1,5- methylpiperidinecarbonyl)piperidin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione (2S,4R)-N-cyclopentyl((3-(2,4- (2S,4R)((3-(2,4-dioxotetrahydropyrimidindioxotetrahydropyrimidin-1 (2H)- 1(2H)-yl)pyrazolo[1,5-a]pyridinyl)methyl)- azolo[1,5-a]pyridinyl)methyl) N,N,2-trimethylpiperidinesulfonamide methylpiperidinesulfonamide N N N N 1-(5-(((2S,4R)methyl(pyrrolidine )((3-(2,4-dioxotetrahydropyrimidincarbonyl )piperidinyl)methyl)pyrazolo[1,5- 1(2H)-yl)pyrazolo[1,5-a]pyridinyl)methyl)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- N,N,2-trimethylpiperidinecarboxamide dione (2S,4R)-N-cyclopentyl((3-(2,4- 1-(5-((1-(pyrrolidinylsulfonyl)piperidin dioxotetrahydropyrimidin-1(2H)- yl)methyl)pyrazolo[1,5-a]pyridin yl)pyrazolo[1,5-a]pyridinyl)methyl) yl)dihydropyrimidine-2,4(1H,3H)-dione methylpiperidinecarboxamide N-cyclopentyl((3-(2,4- (2S,4R)((3-(2,4-dioxotetrahydropyrimidindioxotetrahydropyrimidin-1 (2H)- 1(2H)-yl)pyrazolo[1,5-a]pyridinyl)methyl)- azolo[1,5-a]pyridin N-ethyl-N,2-dimethylpiperidine yl)methyl)piperidinesulfonamide carboxamide 1-(5-((1-(((1s,3s) 1-(5-((1-(((1r,3R,4S)-3,4- methoxycyclobutyl)methyl)piperidin difluorocyclopentyl)methyl)piperidin hyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione N N N 1-(5-(((2S,4R)(((1r,3S) 1-(5-(((2S,4R)(((1s,3R) methoxycyclobutyl)methyl)methylpiperidin- methoxycyclobutyl)methyl)methylpiperidin- 4-yl)methyl)pyrazolo[1,5-a]pyridin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione ydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)(((1r,3R,4S)-3,4- 1-(5-(((2S,4R)methyl(((1r,4S) difluorocyclopentyl)methyl)methylpiperidin- (trifluoromethyl)cyclohexyl)methyl)piperidin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)(((R)-3,3- 1-(5-(((2S,4R)(((S)-3,3- difluorocyclopentyl)methyl)methylpiperidin- difluorocyclopentyl)methyl)methylpiperidin- 4-yl)methyl)pyrazolo[1,5-a]pyridin 4-yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4S)((4,4- 1-(5-(((2S,4R)((4,4- difluorocyclohexyl)methyl)fluoro rocyclohexyl)methyl)fluoro methylpiperidinyl)methyl)pyrazolo[1,5- methylpiperidinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione 1-(5-(((2S,4S)fluoromethyl(oxetan 1-(5-(((2S,4R)fluoromethyl(oxetan yl)piperidinyl)methyl)pyrazolo[1,5- yl)piperidinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione (R)(5-((octahydro-2H-pyrido[1,2-a]pyrazin- 1-(5-((1-isobutyl(trifluoromethyl)piperidin 2-yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (R)(5-((4-oxohexahydropyrazino[2,1- (S)(5-((1,1-dioxidohexahydro-5H- c][1,4]oxazin-8(1H)-yl)methyl)pyrazolo[1,5- isothiazolo[2,3-a]pyrazin dinyl)dihydropyrimidine-2,4(1H,3H)- yl)methyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione ((S)(((1r,3S) 1-(5-(((S)(((1s,3R) methoxycyclobutyl)methyl) methoxycyclobutyl)methyl) methylpiperazinyl)methyl)pyrazolo[1,5- methylpiperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione 1-(5-(((S)(((1r,3R,4S)-3,4- 1-(5-(((S)(((R)-3,3- difluorocyclopentyl)methyl) difluorocyclopentyl)methyl) methylpiperazinyl)methyl)pyrazolo[1,5- methylpiperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione ((S)(((S)-3,3- (S)(5-((4-(cyclopropylmethyl) difluorocyclopentyl)methyl) methylpiperazinyl)methyl)pyrazolo[1,5- methylpiperazinyl)methyl)pyrazolo[1,5- dinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione 1-(5-(((S)methyl(((1r,4S) (S)(5-((3-methyl((1- (trifluoromethyl)cyclohexyl)methyl)piperazinmethylcyclobutyl )methyl)piperazin 1-yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(5-(((3S)methyl(oxetan (S)(5-((4-((2-oxaspiro[3.3]heptan ylmethyl)piperazinyl)methyl)pyrazolo[1,5- yl)methyl)methylpiperazin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- hyl)pyrazolo[1,5-a]pyridin dione yl)dihydropyrimidine-2,4(1H,3H)-dione (S)(5-((4-((6,6-difluorospiro[3.3]heptan (S)(5-((4-(2,2-difluoroethyl) yl)methyl)methylpiperazin methylpiperazinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione (S)(5-((4-(2,2-difluoromethoxypropyl) (S)(5-((4-cyclobutylmethylpiperazin methylpiperazinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione (S)(5-((3-methyl(tetrahydro-2H-pyran (5-((3-methyl(oxetanyl)piperazinyl )piperazinyl)methyl)pyrazolo[1,5- 1-yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione (S)(5-((3-methyl(2-oxaspiro[3.3]heptan- (S)(5-((4-cyclohexylmethylpiperazin 6-yl)piperazinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione (S)(5-((4-(4,4-difluorocyclohexyl) (S)(5-((3-methyl(spiro[3.3]heptan methylpiperazinyl)methyl)pyrazolo[1,5- yl)piperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione (S)(5-((3-methyl(2-methyl (S)(5-((3-methyl(2-(methylsulfonyl) ro[3.3]heptanyl)piperazin ro[3.3]heptanyl)piperazin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (S)(5-((4-(ethylsulfonyl)methylpiperazin- 1-(5-((4-cyclohexylpiperazin 1-yl)methyl)pyrazolo[1,5-a]pyridin hyl)pyrazolo[1,5-a]pyridin yl)dihydropyrimidine-2,4(1H,3H)-dione yl)dihydropyrimidine-2,4(1H,3H)-dione (S)(5-((4-(cyclopropanecarbonyl) (S)(5-((4-isobutyrylmethylpiperazin methylpiperazinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione (S)(5-((4-(cyclohexanecarbonyl) (S)(5-((4-(cyclopentanecarbonyl) methylpiperazinyl)methyl)pyrazolo[1,5- methylpiperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- dione dione (5-((4-(cyclobutanecarbonyl) 1-(5-(1-(4-isobutylpiperazin methylpiperazinyl)methyl)pyrazolo[1,5- yl)ethyl)pyrazolo[1,5-a]pyridin a]pyridinyl)dihydropyrimidine-2,4(1H,3H)- yl)dihydropyrimidine-2,4(1H,3H)-dione dione 1-(5-(((2S,4R)isobutylmethylpiperidin 1-(5-(((2S,4R)isobutylmethylpiperidin yl)methyl)pyrazolo[1,5-a]pyridin yl)methyl)pyrazolo[1,5-a]pyridinyl) yl)pyrimidine-2,4(1H,3H)-dione methylpyrimidine-2,4(1H,3H)-dione 1-(5-(((2S,4R)(cyclopropylmethyl) 5-fluoro(5-(((2S,4R)isobutyl methylpiperidinyl)methyl)pyrazolo[1,5- methylpiperidinyl)methyl)pyrazolo[1,5- a]pyridinyl)methylpyrimidinea ]pyridinyl)pyrimidine-2,4(1H,3H)-dione 2,4(1H,3H)-dione 1-(5-(((2S,4R)((4,4- 1-(5-(((2S,4R)((4,4- difluorocyclohexyl)methyl)methylpiperidin- rocyclohexyl)methyl)methylpiperidin- 4-yl)methyl)pyrazolo[1,5-a]pyridinyl) ethyl)pyrazolo[1,5-a]pyridinyl) fluoropyrimidine-2,4(1H,3H)-dione methylpyrimidine-2,4(1H,3H)-dione 5-chloro(5-(((2S,4R)((4,4- 1-(5-(((2S,4R)((4,4- difluorocyclohexyl)methyl)methylpiperidin- difluorocyclohexyl)methyl)methylpiperidin- ethyl)pyrazolo[1,5-a]pyridin 4-yl)methyl)pyrazolo[1,5-a]pyridinyl) yl)pyrimidine-2,4(1H,3H)-dione methoxypyrimidine-2,4(1H,3H)-dione N N N 5-cyclopropyl(5-(((2S,4R)isobutyl methylpiperidinyl)methyl)pyrazolo[1,5- 1-(5-(((2S,4R)(cyclopropanecarbonyl) piperidinyl)methyl)pyrazolo[1,5- a]pyridinyl)pyrimidine-2,4(1H,3H)-dione a]pyridinyl)pyrimidine-2,4(1H,3H)-dione (S)(5-((4-isobutylmethylpiperazin 1-(5-(((2S,4R)(ethylsulfonyl) yl)methyl)pyrazolo[1,5-a]pyridin methylpiperidinyl)methyl)pyrazolo[1,5- yl)pyrimidine-2,4(1H,3H)-dione a]pyridinyl)pyrimidine-2,4(1H,3H)-dione (S)fluoro(5-((4-isobutyl (S)(5-((4-isobutylmethylpiperazin methylpiperazinyl)methyl)pyrazolo[1,5- yl)methyl)pyrazolo[1,5-a]pyridinyl) a]pyridinyl)pyrimidine-2,4(1H,3H)-dione methylpyrimidine-2,4(1H,3H)-dione N N N (S)(5-((4-isobutylmethylpiperazin (S)cyclopropyl(5-((4-isobutyl yl)methyl)pyrazolo[1,5-a]pyridinyl) methylpiperazinyl)methyl)pyrazolo[1,5- methoxypyrimidine-2,4(1H,3H)-dione a]pyridinyl)pyrimidine-2,4(1H,3H)-dione (S)(5-((4-(cyclopropylmethyl) (S)(5-((4-((4,4-difluorocyclohexyl)methyl)- methylpiperazinyl)methyl)pyrazolo[1,5- 3-methylpiperazinyl)methyl)pyrazolo[1,5- a]pyridinyl)methylpyrimidinea ]pyridinyl)pyrimidine-2,4(1H,3H)-dione 2,4(1H,3H)-dione
16. The nd of any one of claims 1 to 15, or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer f, wherein the pharmaceutically acceptable salt is an acid addition salt.
17. The compound of claim 1, or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, selected from , , , , 10 , and .
18. The nd of claim 1, or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, which is .
19. The compound of claim 1, which is .
20. A pharmaceutical composition comprising a therapeutically effective amount of a compound of any one of claims 1 to 19, or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, and a pharmaceutically acceptable r or excipient. 10
21. A compound of any one of claims 1 to 19, or a ceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, for use as a medicament.
22. A compound of any one of claims 1 to 19, or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, for use in treating a hemoglobinopathy in a subject in 15 need f.
23. A compound of any one of claims 1 to 19, or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, for use in the treatment of a disease or disorder selected from sickle cell e and beta-thalassemia.
24. A compound of any one of claims 1 to 19, or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, for use in treating or preventing a disorder that is affected by the reduction of WIZ protein levels, in a subject in need thereof.
25. 25 25. A compound of any one of claims 1 to 19, or a pharmaceutically able salt, hydrate, solvate, stereoisomer, or tautomer thereof, for use in ng a sickle cell disease in a t in need thereof.
26. A compound of any one of claims 1 to 19, or a ceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer f, for use in treating beta-thalassemia in a subject in need thereof. 5
27. A compound of any one of Claims 1 to 19, or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, for use in the treatment of a disease or disorder affected by an increase in fetal obin expression.
28. A compound of any one of Claims 1 to 19, or a pharmaceutically acceptable salt, hydrate, 10 solvate, stereoisomer, or tautomer thereof, for use in the treatment of a disease or disorder affected by the ion or promotion of fetal hemoglobin.
29. Use of a compound of any one of claims 1 to 19, or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, in the manufacture of a medicament for 15 treating a obinopathy.
30. Use of a compound of any one of claims 1 to 19, or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, in the manufacture of a medicament for treating a disease or disorder that is affected by the reduction of WIZ protein levels, inhibition of 20 WIZ protein expression or degradation of WIZ protein.
31. Use of a compound of any one of claims 1 to 19, or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or er thereof, in the manufacture of a ment for treating a disease or disorder that is affected by inducing or ing fetal hemoglobin.
32. The use of a compound of claim 30 or 31, wherein the disease or disorder is selected from sickle cell disease and beta-thalassemia.
33. A pharmaceutical composition comprising a compound of any one of claims 1 to 19, or a 30 pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, for use in the treatment of a disease or disorder that is affected by the reduction of WIZ protein levels, inhibition of WIZ protein expression or degradation of WIZ protein.
34. A pharmaceutical composition comprising a nd of any one of claims 1 to 19, or a 35 ceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, in the ent of a disease or disorder that is ed by ng fetal hemoglobin, vating fetal hemoglobin production or expression, or increasing fetal hemoglobin expression.
35. The pharmaceutical composition of claim 33 or 34, wherein the disease or disorder is selected from sickle cell disease and beta-thalassemia.
36. A pharmaceutical combination agent comprising a compound of any one of claims 1 to 5 19, or a pharmaceutically acceptable salt, hydrate, solvate, isomer, or tautomer thereof, and one or more additional therapeutic agent(s).
37. A compound of formula (X-1) or a salt thereof, 10 (X-1) wherein: is a single bond or a double bond; X is selected from CH, CF, and N; Z is selected from hydrogen and 2,4-dimethoxybenzyl (DMB); 15 Rx is selected from hydrogen, C1-C6alkyl, halo, C1-C6alkoxyl, and C3-C8cycloalkyl; RN is selected from hydrogen and a nitrogen protecting group PG, wherein the nitrogen protecting group PG is ed from C1-C6alkyl which is mono-, di- or tri-substituted by trialkylsilyl-C1-C7alkoxy, aryl or a heterocyclic group, aryl-C1-C2-alkoxycarbonyl, C1- C10alkenyloxycarbonyl, C1-C6alkylcarbonyl, C6-C10-arylcarbonyl, C1-C6-alkoxycarbonyl, 20 C6-C10-arylC1-C6-alkoxycarbonyl, allyl, cinnamyl, yl, sulfenyl, succinimidyl group, and silyl group; R’ is selected from hydrogen and C1-C6alkyl; R1 is selected from hydrogen and C1-C6alkyl; each R2 is ndently selected from C1-C6alkyl, C1-C6haloalkyl, halo, and oxo, 25 n the C1-C6alkyl is substituted with 0-1 occurrence of R2a; or 2 R2 on non-adjacent carbon atoms together with the non-adjacent carbon atoms to which they are ed form a bridging ring; R2a is selected from C1-C6alkoxyl and hydroxyl; n is 0, 1, 2, 3 or 4; 30 m is 0, 1 or 2; and p is 0 or 1.
38. The compound of claim 1, substantially as herein described with reference to any one of the examples and/or
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163161139P | 2021-03-15 | 2021-03-15 | |
| US202163164130P | 2021-03-22 | 2021-03-22 | |
| PCT/IB2022/052281 WO2022195454A1 (en) | 2021-03-15 | 2022-03-14 | Pyrazolopyridine derivatives and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NZ802195A true NZ802195A (en) | 2025-10-31 |
| NZ802195B2 NZ802195B2 (en) | 2026-02-03 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11129832B2 (en) | Biheteroaryl compounds and uses thereof | |
| US10028942B2 (en) | 3-substituted pyrazoles and uses thereof | |
| AU2013213603B2 (en) | PDE9 inhibitors with imidazo triazinone backbone | |
| JP7073359B2 (en) | Piperidine derivative as an inhibitor of ubiquitin-specific protease 7 | |
| ES2677996T3 (en) | New indazolcarboxamides, procedure for their preparation, pharmaceutical preparations containing them, as well as their use for the preparation of medicines | |
| RU2288222C2 (en) | Derivative of 2-cyano-4-fluoropyrrolidine and its salt | |
| CN106661035B (en) | Pyrazolopyrimidine derivatives useful as inhibitors of Bruton's tyrosine kinase | |
| AU2021242143B2 (en) | Aminopyrimidine derivatives and their use as Aryl hydrocarbon receptor modulators | |
| US20090042856A1 (en) | Pyridazinone derivatives used for the treatment of pain | |
| KR20080094729A (en) | Pyrazoloquinolones are potent parp inhibitors | |
| JP5457476B2 (en) | 6-amino-5-cyano-pyrimidin-4-one compounds used for improving perception, concentration, learning and / or memory | |
| KR20230031851A (en) | Isoxazolidines and their uses as RIPK1 inhibitors | |
| KR101794321B1 (en) | Bicyclic Group Substituted Pyrimidine Compounds | |
| NZ802195B2 (en) | Pyrazolopyridine derivatives and uses thereof | |
| JP2025508839A (en) | Emopamil binding protein inhibitors and uses thereof | |
| WO2024020156A1 (en) | Emopamil-binding protein inhibitors and uses thereof | |
| RU2023126005A (en) | PYRAZOLOPYRIDINE DERIVATIVES AND THEIR APPLICATIONS | |
| WO2025196446A1 (en) | Thiadiazoles as glutaminase 1 inhibitors | |
| OA16957A (en) | PDE9 inhibitors with imidazo triazinone backbone. | |
| HK1209114B (en) | 3-substituted pyrazoles and use as dlk inhibitors | |
| SA07280596B1 (en) | Pyridine Amide Compounds and Their Use as Inhibitors of 11- B- Hydroxysteroid Dehydrogenase Type 1 Enzyme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 MAR 2027 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS Effective date: 20260219 |